Myeloproliferative neoplasms can be associated with bleeding manifestations which can cause significant morbidities. Although haematologists are aware of the likelihood of this complication in the setting of myeloproliferative neoplasms, it may often be overlooked especially in patients with no extreme elevation of blood counts and those with myelofibrosis. Acquired von Willebrand syndrome and platelet dysfunction are the two common diagnoses to be considered in this regard. In this review article, we discuss the mechanisms for the development of these rare bleeding disorders, their diagnosis and practical management.
CITATION STYLE
Jones, E., Dillon, B., Swan, D., & Thachil, J. (2022, November 1). Practical management of the haemorrhagic complications of myeloproliferative neoplasms. British Journal of Haematology. John Wiley and Sons Inc. https://doi.org/10.1111/bjh.18322
Mendeley helps you to discover research relevant for your work.